Literature DB >> 286610

[Normal and modified nucleobases excreted in urine of patients with chronic nyeloproliferative disorders (author's transl)].

G Schöch, M Garbrecht, G Heller-Schöch, H Baisch, W Leifer.   

Abstract

The qualitative and quantitative analysis by high performance liquid chromatography of the normal and modiefied nucleobases excreted in urine represents a new and versatile tool, especially in oncology. The excretion of 2 normal (adenine, guanine) and 4 modified nucleobases (methylated guanine derivatives) in urine was measured by cation exchange LC. All chronic myeloproliferative syndromes showed highly elevated total excretion values of all determined nucleobases, the "pattern" being characteristic with N2, N2-dimethylguanine most prominent (up to 29.8 S.D. above the pertinent normal value). A follow-up study of a case of CML with two episodes of extreme leukocytosis showed a correlation of the nucleobases excretion with the number of leukocytes. Thus, a method has been established which permits the assessment of myeloproliferation and probably therapy effects.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 286610     DOI: 10.1007/bf01007900

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  10 in total

1.  Some speculations on the myeloproliferative syndromes.

Authors:  W DAMESHEK
Journal:  Blood       Date:  1951-04       Impact factor: 22.113

2.  [Nucleic acid metabolites in urine: measuring methods and significance].

Authors:  G Schöch; W Leifer; R Grüttner
Journal:  Monatsschr Kinderheilkd       Date:  1976-05

3.  High turnover rate of transfer RNA in tumor tissue.

Authors:  E Borek; B S Baliga; C W Gehrke; C W Kuo; S Belman; W Troll; T P Waalkes
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

4.  [Molecular biology and clinical significance of the metabolism of normal and modified nucleobases (author's transl)].

Authors:  G Schöch; G Heller-Schöch
Journal:  Helv Paediatr Acta Suppl       Date:  1977

5.  [Transfer RNA methyltransferases in different hemoblastoses].

Authors:  G Schöch; G Heller-Schöch; K Winkler; R Mertelsmann; M Garbrecht
Journal:  Verh Dtsch Ges Inn Med       Date:  1973

6.  Purine and pyrimidine excretion in Hodgkin's disease.

Authors:  K J Pinkard; I A Cooper; R Motteram; C N Turner
Journal:  J Natl Cancer Inst       Date:  1972-07       Impact factor: 13.506

7.  [Excretion of nucleic degradation products in relation to age and growth].

Authors:  G Schöch; G Heller-Schöch; H Lorenz; H Baisch; M Weser; W Leifer; R Grüttner
Journal:  Monatsschr Kinderheilkd       Date:  1977-05

8.  Methylation and processing of transfer ribonucleic acid in mammalian and bacterial cells.

Authors:  T W Munns; H F Sims
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

9.  The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.

Authors:  T P Waalkes; C W Gehrke; R W Zumwalt; S Y Chang; D B Lakings; D C Tormey; D L Ahmann; C G Moertel
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

10.  A method for the determination of xanthine and hypoxanthine in biological fluids.

Authors:  H A Simmonds; J D Wilson
Journal:  Clin Chim Acta       Date:  1967-04       Impact factor: 3.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.